Startups

Anaconda Biomed logo

Anaconda Biomed

Sant Quirze del Vallès, Barcelona, Spain

Anaconda Biomed S.L. is a Barcelona-area medical-device company developing funnel-based endovascular access and protection technology for neurovascular interventions, including mechanical thrombectomy in acute ischemic stroke caused by large-vessel occlusion. Co-founded in2015 by neurologist Marc Ribó and biomedical materials scientist Ofir Arad, it is registered in Spain under tax numberB66513474 and manufactures in Sant Quirze del Vallès. Its platform combines a self-expanding nitinol funnel, aspiration and temporary vascular-flow restriction, with devices intended to support clot retrieval and reduce downstream embolization. Clinical outcomes remain subject to the relevant product studies and indications. The issuer identifies ANA5 as CE-mark approved and the ANA Funnel Catheter as investigational-only in the United States. Its ongoing ATHENA pivotal IDE study is a prospective randomized327-subject trial. Trent Reutiman leads the company asCEO, alongside a published eight-person management team, external clinical scientific advisers and board representatives from its specialist healthcare investors. A closedUSD56M financing announced September23,2026 supports clinical development, manufacturing and regulatory work; the record separately identifies prior equity financings, investment commitments, public grant support and its signed EIB venture-debt facility.

Founded 2015

Team

Christophe CognardChristophe CognardScientific Advisory Board Member (external clinician)
Chuck CarignanChuck CarignanBoard Chairman
Claudio NessiClaudio NessiBoard Director
Iñaki GalveIñaki GalveR&D Director
Jordi CardonaJordi CardonaOperations Director
Marc RibóMarc RibóCo-Founder and Scientific Advisory Board Member (external clinician)
Marco VenturelliMarco VenturelliBoard Director
Maria Jose AlonsoMaria Jose AlonsoFinance Director
Monica BarrettMonica BarrettRA/QA Director
Ofir AradOfir AradCo-Founder and Managing Director · Board Director
Raul G. NogueiraRaul G. NogueiraScientific Advisory Board Member (external clinician)
Sylvain SachotSylvain SachotBoard Director
Thomas HarthThomas HarthBoard Director
Tina CordaroTina CordaroVP, Clinical Affairs
Tommy AnderssonTommy AnderssonScientific Advisory Board Member (external clinician)
Trent ReutimanTrent ReutimanCEO · Board Director
Tudor JovinTudor JovinScientific Advisory Board Member (external clinician)

Investments

$56M2026-09-23Omega Funds, Ysios Capital, Asabys Partners, CDTI-Innvierte
$—2025-01-09Ysios Capital, Asabys Partners, CDTI-Innvierte
$—2021-07-290 participations
€20M2019-12-04Asabys Partners, Origine SGR, Ysios Capital, Omega Funds
€15M2017-05-22Origine SGR, Ysios Capital, Omega Funds
$—Unknown dateCDTI
$—Unknown dateTNBT Capital
$—Unknown dateEIT Health
$—Unknown dateOrigine SGR